首页> 美国卫生研究院文献>Pharmacy: Journal of Pharmacy Education and Practice >Validating the Modified Drug Adherence Work-Up (M-DRAW) Tool to Identify and Address Barriers to Medication Adherence
【2h】

Validating the Modified Drug Adherence Work-Up (M-DRAW) Tool to Identify and Address Barriers to Medication Adherence

机译:验证修改后的药物依从性检查(M-DRAW)工具以识别和解决药物依从性的障碍

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Barriers to medication adherence stem from multiple factors. An effective and convenient tool is needed to identify these barriers so that clinicians can provide a tailored, patient-centered consultation with patients. The Modified Drug Adherence Work-up Tool (M-DRAW) was developed as a 13-item checklist questionnaire to identify barriers to medication adherence. The response scale was a 4-point Likert scale of frequency of occurrence (1 = never to 4 = often). The checklist was accompanied by a GUIDE that provided corresponding motivational interview-based intervention strategies for each identified barrier. The current pilot study examined the psychometric properties of the M-DRAW checklist (reliability, responsiveness and discriminant validity) in patients taking one or more prescription medication(s) for chronic conditions. A cross-sectional sample of 26 patients was recruited between December 2015 and March 2016 at an academic medical center pharmacy in Southern California. A priming question that assessed self-reported adherence was used to separate participants into the control group of 17 “adherers” (65.4%), and into the intervention group of nine “unintentional and intentional non-adherers” (34.6%). Comparable baseline characteristics were observed between the two groups. The M-DRAW checklist showed acceptable reliability (13 item; alpha = 0.74) for identifying factors and barriers leading to medication non-adherence. Discriminant validity of the tool and the priming question was established by the four-fold number of barriers to adherence identified within the self-selected intervention group compared to the control group (4.4 versus 1.2 barriers, p < 0.05). The current study did not investigate construct validity due to small sample size and challenges on follow-up with patients. Future testing of the tool will include construct validation.
机译:药物依从性的障碍源于多种因素。需要一种有效且方便的工具来识别这些障碍,以便临床医生可以为患者提供量身定制的以患者为中心的咨询服务。修改后的药物依从性检查工具(M-DRAW)是作为13个项目的清单调查表而开发的,旨在确定药物依从性的障碍。响应量表是出现频率的4点李克特量表(1 =从不到4 =经常)。该清单随附有一个GUIDE,该GUIDE为每个已发现的障碍提供了相应的基于动机访谈的干预策略。当前的先导研究检查了服用一种或多种慢性病处方药的患者的M-DRAW检查表的心理计量学特性(可靠性,反应性和区分效度)。在2015年12月至2016年3月期间,从南加州的一家学术医疗中心药房招募了26名患者的横断面样本。评估自我报告依从性的一个主要问题用于将参与者分为对照组的17个“坚持者”(65.4%)和干预组的9个“无意和有意的非坚持者”(34.6%)。两组之间观察到可比较的基线特征。 M-DRAW清单显示出可接受的可靠性(13项;α= 0.74),可用于识别导致药物不依从的因素和障碍。该工具和启动问题的判别有效性是由自我选择的干预组中识别出的坚持障碍的四倍数量(与对照组相比,分别为4.4和1.2个障碍,p <0.05)确定的。由于样本量小和患者随访困难,目前的研究未调查构建体的有效性。该工具的未来测试将包括构造验证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号